SHINVA(SH:600587)2023-04-27 16:00Financial Performance - Total operating revenue for Q1 2023 reached ¥2,438,890,277.93, representing a 15.42% increase compared to ¥2,112,972,293.22 in Q1 2022[11] - Net profit attributable to shareholders for Q1 2023 was ¥196,511,980.14, a significant increase of 54.01% from the previous year's ¥127,600,000[11] - The net profit after deducting non-recurring gains and losses was ¥183,670,392.01, reflecting a 23.75% increase year-over-year[11] - Basic earnings per share for Q1 2023 were ¥0.46, up 48.39% from ¥0.31 in Q1 2022[11] - Net profit for Q1 2023 reached ¥202,032,967.27, compared to ¥129,776,153.67 in Q1 2022, marking an increase of about 55.8%[31] Cash Flow - The net cash flow from operating activities for Q1 2023 was ¥16,134,620.03, showing a remarkable increase of 104.57% compared to the same period last year[11] - The cash inflow from operating activities was CNY 2,677,674,550.70, an increase of 5.4% compared to CNY 2,540,053,632.68 in Q1 2022[35] - The net cash flow from operating activities was CNY 16,134,620.03, a significant improvement from a negative CNY 353,160,624.57 in the same period last year[35] - The cash outflow for purchasing goods and services decreased to CNY 1,833,717,572.07 from CNY 2,004,044,670.26, reflecting a reduction of approximately 8.5%[35] - Cash inflow from financing activities increased significantly to CNY 1,618,114,291.24, compared to CNY 694,069,268.00 in the previous year, marking a growth of approximately 133.3%[36] Assets and Liabilities - Total assets as of the end of Q1 2023 amounted to ¥14,329,504,437.67, a 10.64% increase from ¥12,951,981,234.86 at the end of the previous year[13] - The company's total liabilities decreased to ¥7,049,282,720.17 from ¥7,162,680,947.62, a reduction of approximately 1.6%[28] - The total equity attributable to shareholders rose to ¥6,878,350,191.11, up from ¥5,393,129,480.26, reflecting an increase of around 27.6%[28] - Cash and cash equivalents amounted to approximately 2.72 billion yuan, up from 1.69 billion yuan at the end of 2022[26] - Inventory increased to ¥3,080,408,088.29 from ¥3,028,718,658.95, showing a growth of about 1.7%[27] Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 20,300[16] - The largest shareholder, Shandong Yiyang Health Industry Development Group, holds 28.90% of shares[19] - The company reported no significant changes in shareholder relationships or actions during the reporting period[20] Research and Development - Research and development expenses for Q1 2023 were ¥73,557,725.07, an increase from ¥54,260,023.18 in Q1 2022[11] Fair Value Changes - The company reported a fair value change gain of ¥18,316,041.72 in Q1 2023, compared to a loss of ¥21,070,476.47 in the same period last year[11] - Net profit attributable to shareholders rose by 54.01%, driven by increased operating revenue and fair value changes of certain stocks[15] Other Financial Metrics - Long-term borrowings increased to ¥119,266,409.44 from ¥96,326,409.44, representing a growth of about 23.8%[28] - The company's contract assets rose to ¥110,129,035.02 from ¥98,631,827.22, an increase of approximately 11.5%[27] - The total non-current assets increased to ¥5,781,873,341.28 from ¥5,566,967,093.96, reflecting a growth of about 3.9%[27] - The net cash flow from investing activities was negative CNY 139,927,754.81, worsening from negative CNY 64,632,017.25 in Q1 2022[36] - The ending balance of cash and cash equivalents reached CNY 2,507,326,131.84, a substantial increase from CNY 1,147,806,980.50 at the end of Q1 2022[36]